PERCEPTIVE ADVISORS LLC

Position in DBVT — DBV Technologies S.A.

CIK 1224962 NEW YORK, NY

Position in DBVT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$27,114,940

+$6,968,813 QoQ

Shares Held

1,653,350

+71.4% QoQ

Ownership

0.558%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

of 78 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. DBVT ranks #37 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	2,035,986	$681,627,752
2	SYRE	Spyre Therapeutics, Inc.	4,319,496	$383,484,854
3	CELC	Celcuity Inc.	3,197,200	$334,491,064
4	ASND	Ascendis Pharma A/S	1,163,721	$310,387,665
5	RYTM	Rhythm Pharmaceuticals, Inc.	2,586,295	$287,156,333
6	ROIV	Roivant Sciences Ltd.	8,085,461	$286,144,464
7	RLAY	Relay Therapeutics, Inc.	14,106,187	$263,926,758
8	TVTX	Travere Therapeutics, Inc.	3,752,574	$213,183,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,114,940	1,653,350	+71.4%	Shares	Sole	2026-08-14
2026-03-31	$20,146,127	964,391	-87.5%	Shares	Sole	2026-05-29
2021-09-30	$37,707,974	7,695,505	0.0%	Shares	Sole	2021-12-03
2021-06-30	$42,017,457	7,695,505	0.0%	Shares	Sole	2021-08-16
2021-03-31	$41,017,041	7,695,505	+16.7%	Shares	Sole	2021-08-13
2020-12-31	$17,280,223	6,595,505	-3.1%	Shares	Sole	2021-02-16
2020-09-30	$11,776,066	6,806,975	-7.0%	Shares	Sole	2020-11-16
2020-06-30	$32,125,181	7,317,809	0.0%	Shares	Sole	2020-08-17
2020-03-31	$28,685,811	7,317,809	—	Shares	Sole	2020-05-18
No filing history on record for this holder in this stock.